Kaleido Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KLDO research report →
About the company
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19.
- CEO
- Mark A. Wingertzahn
- IPO
- 2019
- Employees
- 76
- HQ
- Lexington, MA, US
Price Chart
- Market Cap
- $4.26K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.20
- Div Yield
- 0.00%
- Gross Margin
- -113.59%
- Op Margin
- -7940.85%
- Net Margin
- -8178.26%
- ROE
- -580.57%
- ROIC
- -239.53%
- Revenue
- $1.10M · 13.23%
- Net Income
- $-90,288,000 · -10.62%
- EPS
- $-2.16 · 11.48%
- Op Income
- $-87,667,000
- FCF YoY
- -19.35%
- 52W High
- $0.20
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.17
- Avg Volume
- 1.87K
Get TickerSpark's AI analysis on KLDO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 28, 22 | van Hylckama Vlieg Johan | other | 2,087 |
| Feb 28, 22 | Korn Jerald | other | 2,046 |
| Jan 14, 22 | van Hylckama Vlieg Johan | other | 350,000 |
| Jan 14, 22 | Long Alison S | other | 125,000 |
| Jan 14, 22 | Long Alison S | other | 46,800 |
| Jan 14, 22 | Korn Jerald | other | 250,000 |
| Jan 14, 22 | Korn Jerald | other | 45,240 |
| Jan 14, 22 | Duke William E. | other | 125,000 |
| Jan 14, 22 | Duke William E. | other | 44,990 |
| Jan 14, 22 | Menichella Daniel L | other | 250,000 |
Our KLDO coverage
Recent articles, reports, and earnings notes.
No research on KLDO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KLDO report →Similar companies
Peers in the same neighborhood.